Christopher W. Kennedy

Christopher W. Kennedy is an award-winning healthcare leader. He has spent the last

two decades in executive leadership roles within the Healthcare Provider, Biotechnology,

and Medical Device sectors. His efforts in making Patient Experience a measurable

outcome have been featured by The Beryl Institute, The Wharton School, a PBS TV

Special, and a 2019 Ted Talk presentation. He actively serves on multiple industry

advisory boards including MOBIO, URAC, NASP, and The Kauffman Foundation's Skilled

KC initiative.

Christopher is recognized for pioneering innovative healthcare solutions. Currently, his

focus is in the new drug development space specific to hematopoietic (HSC) and

mesenchymal (MSC) stem cell research. He is leading a world-renowned scientific team

in launching the first out-licensed technology from the Stowers Institute for Medical

Research. Previously, Christopher was presented with the 2018 American Telemedicine

Association (ATA) President's Award for Innovation for developing a virtual solution for

rare disease care management. The Massachusetts Institute of Technology (MIT)

“Hacking Medicine” program also highlighted Christopher’s work as a top-ranked

breakthrough.

Christopher credits his time at The Wharton School for learning the fundamentals of

"Innovation Tournaments" to more rapidly deliver critical healthcare solutions. He also

studied under Michael Porter and Robert Kaplan at Harvard Business School’s Value-

Based Care program to adopt the fundamentals of Time-Driven Activity-Based Costing

(TDABC) for the launch of forward-looking healthcare models.